Obesity/ Type 2 Diabetes Flashcards

1
Q

what is BMI? what are the different classifications?

A

under 24- lean
24-29.9- overweight
30-39.9- obese
over 40- morbidly obese

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

metabolic syndrome

A

problems that accompany obesity d/t excess caloric intake

1 obesity
2 dyslipidemia (increase FA and VLDL)
3 hepatic steatosis (fatty liver)
4 atherosclerosis
5 insulin resistance
6 hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

after a certain threshold, all excess energy is stored as what?

A

fat

this goes for carbs protein and fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how does excess fat cause insulin resistance?

A

insulin resistance is hyperinsulinemia but normoglycemia

this happens b/c of inhibtion at the insulin receptors ability to phosphorylate IRS-1 during signal transduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the inflammation theory of insulin resistance

A

increased adipose mass causes cytokine release that attracts inflammatory macrophages. these macrophages secrete inflammatory cytokines which activate JNK kinase, which is capable of phosphorylating IRS-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the intracellular triglyceride theory of insulin resistance

A

increased build up of TG in cells leads to increase in intracellular DAG, which acts as an agonist at PKC theta, a protein kinase that phosphorylates IRS-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe the progression of diabetes 2

A

positive energy balance

weight gain

insulin resistance

early T2DM

late T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

difference between early and late diabetes?

A

early- has hyperinsulinemia and hyperglycemia

late- hyperglycemia and hypoinsulinemia d/t pancreatic beta cell loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how are beta cells activated to secrete insulin

A

glucose enters through GLUT2 (always active and not effected by insulin)

glucokinase phosphorylates glucose that enters the cell. glucokinase hasa high Km, so phosphorylation is concentration dependent

glucose goes through the glycolytic pathway, raising ATP/ADP ratio

new ATP inhibits voltage sensitive K channel

causes depolarization that releases Ca granules- releases insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mutations in beta cells linked to diabetes

A

glucokinase

potassium channel

upregulated UCP (decreases ATP generated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what factors lead to hepatic steatosis

A

increased TG from diet

insulin resistance in adipocytes means HSL is active and blood FA rises

upregulated FA transcription factors SREPB-1 and ChREBP

increased malonyl-CoA causes FA synthesis and decreased FA oxidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe the role of SERPB-1 and ChREBP

A

SREPB-1- activated by the increased insulin, activates FA synthesis genes

ChREPB- activated by glucose- increases FA synthesis genes, activates pyruvate kinase (glycolysis), which leads to an increase in citrate, which means more FA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how is gluconeogenesis affected by insulin resistance?

A

AKT is insulin sensitive and thus it is inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

orlistat

A

pancreatic lipase inhibitor
triglyceride stays in gut and is excreted

side effects:
mal absorption of fat soluble vitamins
loose, oily stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

rimonabant

A

cannabinoid receptor antagonist acting in hypothalamus to suppress orexigenic effects of endogenous cannabinoids

withdrawn from market d/t depression side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

sibutramine

A

blocks reuptake of norepeinphrine and serotonin (both suppress appetite)

prevents rebound after weight loss

removed from market d/t CV and stroke

17
Q

what is the order of treatments given to diabetics?

A
  1. exercise/metformin
  2. insulin
    3 sulfonoureas
    4 thiazolidinediones
18
Q

how does exercise help diabetics

A
  1. enhanced GLUT4
    2 increased catabolism
  2. long term transcription increase in GLUT4, mitochondria, etc.
    4 AMPK- activated by increased AMP, phosphorylates ACC to stop FA synthesis
19
Q

what does metformin do?

A

decrease hepatic gluconeogenesis

also:
decrease lipolysis
increase GLUT4
increase FA oxidation

20
Q

advantages/disadvantages of exercise/metformin

A
advantages:
low risk of hypoglycemia
low risk of weight gain
cheap
metformin is oral
21
Q

insulin effects

A

increased glucose uptake
decreased gluconeogenesis
decreased FA oxidation
increased fat storage

22
Q

benefits/risks of insulin

A

advantages- drops blood glucose

disadvantages
injection
hypoglycemia
weight gain
hepatic steatosis
23
Q

sulfonoureas effect

A

inhibit pancreatic K channel, causing increased insulin release

24
Q

sulfonoureas risk/benefit

A

advantages: oral
disadvantages: modest blood glucose lowering, hypoglycemia, weight gain

25
Q

incretin

A

GLP-1 or GIP- increase beta cell sensitivity to glucose and decrease glucagon release

require elevated blood glucose to work

26
Q

two therapies based off incretins

A

DPP4 inhibitors- DPP4 rapidly degrades incretins. taken orally

incretin analogues- must be injected, but DPP4 doesnt bind as well

27
Q

advantages of incretins

A
  1. b/c need elevated blood glucose to work, hypoglycemia not a risk

2 lower risk of weight gain b/c no direct insulin release

3 incretins do not “exhaust” beta cells

28
Q

thiazolidinediones effects

A

PPAR-y agonist

1 increase adipogenesis
2 increase FA uptake into adipocytes

lowers insulin sensitivity by:
1 lowering TG in non adipocyte tissues
2. lowering adipocyte stress

29
Q

risk benefit of thiazolidinediones

A

advan- oral

disadvan- moderate blood glucose lowering, hypoglycemia, weight gain, heart attack, osteoporosis